EpiBiologics vs Grafana Labs

Side-by-side comparison of AI visibility scores, market position, and capabilities

Grafana Labs leads in AI visibility (45 vs 29)
EpiBiologics logo

EpiBiologics

EmergingBioTech

Targeted Protein Degradation

Raised $107M Series B (Jan 2026) co-led by J&J Ventures and Google Ventures. EpiTAC targets membrane and secreted proteins — expanding degradation beyond intracellular-only. EPI-326 entering Phase 1 H1 2026.

AI VisibilityBeta
Overall Score
D29
Category Rank
#1 of 1
AI Consensus
64%
Trend
up
Per Platform
ChatGPT
36
Perplexity
25
Gemini
22

About

EpiBiologics develops EpiTAC — a targeted protein degradation platform designed to eliminate membrane and secreted proteins that existing degrader technologies cannot reach. The company raised $107 million in Series B financing in January 2026, co-led by Johnson & Johnson Ventures and Google Ventures, a rare investor pairing that brings both pharma development expertise and computational biology capabilities. The lead program, EPI-326 (an EGFR degrader for non-small cell lung cancer), is entering Phase 1 clinical trials in the first half of 2026.

Full profile
Grafana Labs logo

Grafana Labs

ChallengerIT Operations & Observability

Metrics Visualization

Open-source observability leader with $6B valuation; Grafana dashboards plus Loki/Tempo/Mimir stack serving millions of installations as Datadog alternative with community-driven adoption.

AI VisibilityBeta
Overall Score
C45
Category Rank
#1 of 1
AI Consensus
62%
Trend
down
Per Platform
ChatGPT
46
Perplexity
41
Gemini
36

About

Grafana Labs is the company behind Grafana — the world's most widely used open-source observability and data visualization platform — providing the Grafana Cloud managed service, Grafana Enterprise, and a suite of open-source tools including Loki (log aggregation), Tempo (distributed tracing), and Mimir (long-term Prometheus metrics storage). Founded in 2019 by Raj Dutt, Torkel Ödegaard, and Tom Wilkie (the creators of the original Grafana open-source project) in New York, Grafana Labs has raised over $600 million at a $6 billion valuation.\n\nGrafana's open-source project — downloadable and self-hostable for free — has driven extraordinary community adoption: millions of Grafana installations globally power engineering, IoT, and business dashboards at organizations from startups to large enterprises. Grafana's plugin ecosystem connects to 200+ data sources (Prometheus, InfluxDB, Elasticsearch, AWS CloudWatch, databases), making it the universal observability visualization layer. Grafana Cloud packages the open-source tools into a fully managed SaaS offering with unlimited metrics, logs, traces, and dashboards.\n\nIn 2025, Grafana Labs competes in the observability platform market against Datadog, New Relic, Dynatrace, and the ELK/OpenSearch stack for enterprise monitoring and observability. Grafana's open-source-first model creates a moat through developer community and ecosystem — engineers who build personal dashboards on Grafana become advocates for Grafana Cloud at their employers. The company's OpenTelemetry alignment and multi-source data philosophy ("query any data, anywhere") differentiates it from Datadog's monolithic agent model. The 2025 strategy focuses on growing Grafana Cloud enterprise adoption, advancing AI-powered Sift (automatic anomaly investigation), and expanding the Grafana IRM (incident response management) product.

Full profile

AI Visibility Head-to-Head

29
Overall Score
45
#1
Category Rank
#1
64
AI Consensus
62
up
Trend
down
36
ChatGPT
46
25
Perplexity
41
22
Gemini
36
28
Claude
53
34
Grok
46

Key Details

Category
Targeted Protein Degradation
Metrics Visualization
Tier
Emerging
Challenger
Entity Type
brand
company

Capabilities & Ecosystem

Capabilities

Only EpiBiologics
Targeted Protein Degradation
Only Grafana Labs
Metrics Visualization

Integrations

Only Grafana Labs
Grafana Labs is classified as company.

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.